Abstract
Purpose: The immunologic effects of radiation (RT) are influenced by RT dose and each may be optimized over a unique dose range. We hypothesized that a heterogeneous dose of RT might thereby optimally engage multiple immune pathways and allow for greater immune activation compared to homogenous RT dose. We used brachytherapy (BT) to deliver a heterogeneous RT dose within a single tumor and we compared the relative capacities of BT and homogenous dose external beam radiotherapy (EBRT) to enhance the anti-tumor immune response in combination with immune checkpoint inhibition (ICI).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
